已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)

替扎尼定 医学 不良事件报告系统 不利影响 药理学 麻醉 内科学 痉挛
作者
Lorenzo Villa‐Zapata,Ainhoa Gómez-Lumbreras,John R. Horn,Malinda S. Tan,Richard D. Boyce,Daniel C. Malone
出处
期刊:Drug Safety [Adis, Springer Healthcare]
卷期号:45 (8): 863-871 被引量:9
标识
DOI:10.1007/s40264-022-01200-4
摘要

Tizanidine is primarily metabolized via cytochrome P450 (CYP) 1A2 and therefore medications that inhibit the enzyme will affect the clearance of tizanidine, leading to increased plasma concentrations of tizanidine and potentially serious adverse events.Our aim was to study the occurrence of adverse events reported in the FDA Adverse Event Reporting System (FAERS) involving the combination of tizanidine and drugs that inhibit the metabolic activity of CYP1A2.A disproportionality analysis of FAERS reports from 2004 quarter 1 through 2020 quarter 3 was conducted to calculate the reporting odds ratio (ROR) of reports mentioning tizanidine in a suspect or interacting role or having any role, a CYP1A2 inhibitor, and the following adverse events: hypotension, bradycardia, syncope, shock, cardiorespiratory arrest, and fall or fracture.A total of 89 reports were identified mentioning tizanidine, at least one CYP1A2 inhibitor, and one of the adverse events of interest. More than half of the reports identified tizanidine as having a suspect or interacting role (n = 59, 66.3%), and the reports more frequently involved women (n = 58, 65.1%). The median age was 56.1 years (standard deviation 17.1). Some of the important safety signals included interactions between tizanidine in a suspect or interacting role and ciprofloxacin (ROR for hypotension 28.1, 95% confidence interval [CI] 19.2-41.2) or fluvoxamine (ROR for hypotension 36.9, 95% CI 13.1-103.4), and also when reported in "any role" with ciprofloxacin (ROR for hypotension 6.3, 95% CI 4.7-8.5), fluvoxamine (ROR for hypotension 11.4, 95% CI 4.5-28.8), and zafirlukast (ROR for falls 16.0, 95% CI 6.1-42.1).Reports involving tizanidine and a CYP1A2 inhibitor have higher odds of reporting hypotension. This study suggests that concurrent use of tizanidine with CYP1A2 inhibitors may lead to serious health consequences associated with low blood pressure such as falls and fractures.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
葡紫明完成签到 ,获得积分10
2秒前
wqw完成签到,获得积分10
3秒前
郑雅茵发布了新的文献求助30
4秒前
Zion完成签到,获得积分0
4秒前
7秒前
领导范儿应助皮崇知采纳,获得10
7秒前
令宏发布了新的文献求助10
8秒前
12秒前
12秒前
13秒前
皮崇知完成签到,获得积分10
14秒前
科研废物完成签到 ,获得积分10
17秒前
7777发布了新的文献求助10
17秒前
皮崇知发布了新的文献求助10
18秒前
西门浩宇完成签到 ,获得积分10
21秒前
碳酸芙兰完成签到,获得积分10
25秒前
CipherSage应助糟糕的铁锤采纳,获得10
25秒前
万能图书馆应助马鑫燚采纳,获得10
25秒前
小六九完成签到 ,获得积分10
26秒前
27秒前
31秒前
猪猪侠发布了新的文献求助10
33秒前
科目三应助满意的世界采纳,获得30
34秒前
Limerencia完成签到,获得积分10
35秒前
38秒前
fsznc1完成签到 ,获得积分0
39秒前
包子完成签到,获得积分10
40秒前
英俊的铭应助7777采纳,获得10
42秒前
45秒前
围炉夜话完成签到,获得积分10
46秒前
科研通AI2S应助科研通管家采纳,获得10
51秒前
汉堡包应助科研通管家采纳,获得10
51秒前
51秒前
54秒前
59秒前
春天先生发布了新的文献求助10
59秒前
1分钟前
ST完成签到,获得积分10
1分钟前
1分钟前
阿满完成签到 ,获得积分10
1分钟前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3965542
求助须知:如何正确求助?哪些是违规求助? 3510831
关于积分的说明 11155263
捐赠科研通 3245323
什么是DOI,文献DOI怎么找? 1792808
邀请新用户注册赠送积分活动 874110
科研通“疑难数据库(出版商)”最低求助积分说明 804176